期刊文献+
共找到49篇文章
< 1 2 3 >
每页显示 20 50 100
Management of Square Carcinoma of the Lower Lip Using Camille-Bernard Flap under Local Anesthesia: When Constraints Dictate Our Attitude
1
作者 Silly Toure Mouhamadou Makhtar Ndiaye +3 位作者 Abibou Ndiaye Mame Sanou Diouf Birame Loum Baye Karim Diallo 《Open Journal of Stomatology》 2024年第4期191-197,共7页
Introduction: Squamous cell carcinomas of the lip essentially pose a therapeutic management problem. In the West, their treatment is done under general anesthesia and follows the classic rules of oncology. In our cont... Introduction: Squamous cell carcinomas of the lip essentially pose a therapeutic management problem. In the West, their treatment is done under general anesthesia and follows the classic rules of oncology. In our context of exercise, we sometimes have a different attitude dictated by various constraints. Observation: 55-year-old patient with no notable history, seen in consultation for a very large ulcerative-budding lesion on the right 2/3 of the lower lip with mucocutaneous involvement without lymph node findings found on examination. Faced with this suspicious lesion and the patient’s financial difficulties, we decided to operate under local anesthesia to remove this tumor. The oncological excision was followed by immediate plasty using a Camille-Bernard flap with a good immediate aesthetic and functional result and postoperative day 7. The patient was unable to take his surgical specimen to anatomy-pathology and was lost to follow-up due to lack of financial resources. On anatomo-pathological analysis of the surgical specimen, the margins were healthy with confirmation of squamous cell carcinoma (anapathological reading made for scientific interest). Discussion: The particular mentality of certain patients and their difficult financial conditions push us to have an unconventional therapeutic attitude in oncology, but which nevertheless makes it possible to resolve certain problems that we often face. Local anesthesia is possible and realistic in cases like ours and the results can be acceptable and life-saving. 展开更多
关键词 squamous cell carcinoma lower Lip Camille Bernard Flap Local Anesthesia
下载PDF
Endu combined with concurrent chemotherapy and radiotherapy for stage IIB-IVA cervical squamous cell carcinoma patients 被引量:1
2
作者 Feng-Ju Zhao Qun Su +3 位作者 Wei Zhang Wen-Cui Yang Lin Zhao Li-Ying Gao 《World Journal of Clinical Cases》 SCIE 2021年第27期8061-8070,共10页
BACKGROUND In recent years,the incidence of cervical cancer has increased with increasing life pressures and changes in women's social roles,posing a serious threat to women's physical and mental health.AIM To... BACKGROUND In recent years,the incidence of cervical cancer has increased with increasing life pressures and changes in women's social roles,posing a serious threat to women's physical and mental health.AIM To explore the clinical effect of Endo combined with concurrent radiotherapy and chemotherapy in the treatment of advanced cervical squamous cell carcinoma.METHODS A total of 120 patients admitted to the oncology department of our hospital were selected as the research subjects.They were equally divided into the test group and the control group(60 patients each)with a random number table.The test group was treated with Endo combined with concurrent radiotherapy and chemotherapy,and the control group was treated with concurrent radiotherapy and chemotherapy.We compared the serum thymidine kinase 1(TK1),human epididymis protein 4(HE4),vascular endothelial growth factor(VEGF),and squamous cell carcinoma-associated antigen(SCC-Ag)levels,the clinical effects and survival before and after radiotherapy and chemotherapy,the quality score,and the 3-year follow-up outcomes between the two groups.RESULTS After chemotherapy,the complete remission+partial remission rate was 85.00%in the test group and 68.33%in the control group;the difference was not statistically significant(P>0.05).Before chemotherapy,the serum TK1,HE4,VEGF,and SCC-Ag levels of the two groups were not significantly different(P>0.05).After chemotherapy,the levels of serum TK1(1.27±0.40 pmol/L),HE4(81.4±24.0 pmol/L),VEGF(235.1±38.0 pg/mL),and SCC-Ag(1.76±0.55 ng/mL)were lower than those in the control group[TK1(1.58±0.51 pmol/L),HE4(98.0±28.6)pmol/L,VEGF(284.2±54.1 pg/mL),and SCC-Ag(2.34±0.78 ng/mL)].The difference was statistically significant(P<0.05).Before chemotherapy,there were no significant differences in the physical,role,mood,cognition,social and symptom scale scores of the two groups(P>0.05).After chemotherapy,the physical,role,mood,cognitive and social scores were higher in the test group than in the control group,and the difference was statistically significant(P<0.05).The symptom scale scores of the test group were all lower than those of the control group,and the difference was statistically significant(P<0.05).The 3-year progression-free survival(PFS)rate was 43.33%in the test group and 26.67%in the control group;the overall survival(OS)rate was 48.33%in the test group and 33.33%in the control group;the differences were not statistically significant(P>0.05).The 3-year PFS time of the test group was 20.0 mo,which was longer than that of the control group(15.0 mo),and the difference was significant(P<0.05).The OS time of the test group was 30.0 mo,which was longer than that of the control group(18.0 mo),and the difference was significant(P<0.05).CONCLUSION Endo combined with concurrent radiotherapy and chemotherapy for the treatment of advanced cervical squamous cell carcinoma has a positive effect on reducing the level of tumor markers in patients,prolonging the PFS and OS times of patients,and improving the quality of life. 展开更多
关键词 ENDO RADIOtheRAPY Chemotherapy middle and late stages Cervical squamous cell carcinoma
下载PDF
GSTM1,GSTT1,GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population:Different pattern of squamous cell carcinoma and adenocarcinoma 被引量:7
3
作者 Ahmed Abbas Karine Delvinquière +4 位作者 Mathilde Lechevrel Pierre Lebailly Pascal Gauduchon Guy Launoy Fran ois Sichel 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第23期3389-3393,共5页
AIM: To evaluate the association between CYPIA1 and GSTs genetic polymorphisms and susceptibility to esophageal squamous cell carcinoma (SCC) and esophageal adenocarcinorna (ADC) in a high risk area of northwest of Fr... AIM: To evaluate the association between CYPIA1 and GSTs genetic polymorphisms and susceptibility to esophageal squamous cell carcinoma (SCC) and esophageal adenocarcinorna (ADC) in a high risk area of northwest of France.METHODS: A case-control study was conducted to investigate the genetic polymorphisms of these enzymes (CYPIAI*2C and GSTP1 exon 7 Val alleles, GSTM1 *2/*2 and GSl-l-l*2/*2 null genotypes). A total of 79 esophagealcancer cases and 130 controls were recruited. RESULTS: GSTM2*2/*2 and CYP1A1*1A/*2C genotype frequencies were higher among squamous cell cardnomas at a level close to statistical significance (OR = 1.83, 95% CI0.88-3.83, P= 0.11; OR = 3.03, 95% CI 0.93-9.90, P= 0.07,respectively). For GSTP1 polymorphism, no difference wasfound between controls and cases, whatever their histological status. Lower frequency of GST/-1 deletion was observed in ADC group compared to controls with a statistically significant difference (OR=13.31, 95% CI 1.66-106.92, P<0.01).CONCLUSION: In SCC, our results are consistent with the strong association of this kind of turnout with tobacco exposure. In ADC, our results suggest 3 distinct hypotheses:(1) activation of exogenous procarcinogens, such as small halogenated compounds by GSTTI', (2) contribution of GSTT1 to the inflammatory response of esophageal mucosa, which is known to be a strong risk factor for ADC,possibly through leukotriene synthesis; (3) higher sensitivity to the inflammatory process associated with intracellular depletion of glutathione. 展开更多
关键词 GSTM1 GSTT1 GSTP1 CYPIA1 遗传多态性 感受性 食道癌 肿瘤 法国人口 鳞状细胞癌 腺癌
下载PDF
Treatment of 104 Cases of Chemotherapy-Induced Leukopenia by Injection of Drugs into Zusanli
4
作者 尹先哲 尹德印 +2 位作者 刘新群 丁旭萌 周永生 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2001年第1期27-28,共2页
From April 1992 to April 1998, 104 cases of chemotherapy-induced leukopenia were treated by injection into Zusanli (ST 36) with a mixture consisting of dexamethasone, 654-2, ATP and inosine. The therapeutic results we... From April 1992 to April 1998, 104 cases of chemotherapy-induced leukopenia were treated by injection into Zusanli (ST 36) with a mixture consisting of dexamethasone, 654-2, ATP and inosine. The therapeutic results were satisfactory as reported in the following. Clinical Data In this series, all the 127 cases were definitely diagnosed by pathological examination. Of them, 93 were male and 34 female, ranging in age from 12 to 75 years. 38 cases were carcinoma of esophagus, 22 carcinoma of cardia of stomach, 21 cancer of lung, 11 hepatic carcinoma, 8 lymphoma, 8 mammary cancer, 7 carcinoma of colon, and 12 other kinds of the tumors. Leukocyte count was below 4.0×109/L in all the patients after being treated by chemotherapy. 展开更多
关键词 针灸点 腺苷 Triphosphate 青少年 成年人 变老 抗肿瘤代理人 有鳞的房间 孩子 地塞米松 食道的瘤 女性 注射 肌甙 白细胞减少 男性 中年 茄科和碱 胃瘤
下载PDF
Ipsilateral synchronous renal pelvic transitional cell carcinoma, squamous cell carcinoma and adenocarcinoma
5
作者 韩平 魏强 +1 位作者 石明 杨宇如 《Chinese Medical Journal》 SCIE CAS CSCD 2004年第10期1590-1591,共2页
关键词 ADENOcarcinoma carcinoma squamous cell carcinoma Transitional cell Female Humans Kidney Neoplasms Kidney Pelvis middle Aged Neoplasms Multiple Primary
原文传递
基于人工智能深度学习算法辅助诊断早期ESCC的研究
6
作者 王娜 温静 +5 位作者 冯佳 卢娜利 刘翠华 智佳 王子阳 黄锦 《胃肠病学和肝病学杂志》 CAS 2024年第2期156-161,共6页
目的探讨基于人工智能(artificial intelligence,AI)深度学习算法的内镜识别系统在胃镜诊疗过程中对早期ESCC检出率的研究。方法选取中国人民解放军联勤保障部队第九八八医院、中国人民解放军联勤保障部队第九八四医院及中国人民解放军... 目的探讨基于人工智能(artificial intelligence,AI)深度学习算法的内镜识别系统在胃镜诊疗过程中对早期ESCC检出率的研究。方法选取中国人民解放军联勤保障部队第九八八医院、中国人民解放军联勤保障部队第九八四医院及中国人民解放军联勤保障部队第九八〇医院三个消化内镜中心2018年6月至2020年6月早期ESCC、ESCC、食管隆起性病变以及食管憩室的白光图像、碘染色图像。通过训练和验证不同的目标检测模型和实例分割模型,最终选取表现最优的目标检测模型Yolov 5和实例分割模型Yolact++共同构建AI“嵌合模型”,评估该模型诊断早期ESCC的性能。结果AI“嵌合模型”对早期ESCC诊断的敏感度为95.60%,特异度为91.60%,准确率为90.70%,均优于单模型。结论本研究构建的AI“嵌合模型”可显著提高早期ESCC的检出率。 展开更多
关键词 人工智能 深度学习 实例分割 食管鳞状细胞癌 碘染色
下载PDF
Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: A systematic review 被引量:43
7
作者 George Sgourakis Ines Gockel Hauke Lang 《World Journal of Gastroenterology》 SCIE CAS 2013年第9期1424-1437,共14页
AIM: To investigate potential therapeutic recommendations for endoscopic and surgical resection of T1a/ T1b esophageal neoplasms. METHODS: A thorough search of electronic databases MEDLINE, Embase, Pubmed and Cochrane... AIM: To investigate potential therapeutic recommendations for endoscopic and surgical resection of T1a/ T1b esophageal neoplasms. METHODS: A thorough search of electronic databases MEDLINE, Embase, Pubmed and Cochrane Library, from 1997 up to January 2011 was performed. An analysis was carried out, pooling the effects of outcomes of 4241 patients enrolled in 80 retrospective studies. For comparisons across studies, each reporting on only one endoscopic method, we used a random effects meta-regression of the log-odds of the outcome of treatment in each study. "Neural networks" as a data mining technique was employed in order to establish a prediction model of lymph node status in superficial submucosal esophageal carcinoma. Another data mining technique, the "feature selection and root cause analysis", was used to identify the most impor-tant predictors of local recurrence and metachronous cancer development in endoscopically resected patients, and lymph node positivity in squamous carcinoma (SCC) and adenocarcinoma (ADC) separately in surgically resected patients. RESULTS: Endoscopically resected patients: Low grade dysplasia was observed in 4% of patients, high grade dysplasia in 14.6%, carcinoma in situ in 19%, mucosal cancer in 54%, and submucosal cancer in 16% of patients. There were no significant differences between endoscopic mucosal resection and endoscopic submucosal dissection (ESD) for the following parameters: complications, patients submitted to surgery, positive margins, lymph node positivity, local recurrence and metachronous cancer. With regard to piecemeal resection, ESD performed better since the number of cases was significantly less [coefficient: -7.709438, 95%CI: (-11.03803, -4.380844), P < 0.001]; hence local recurrence rates were significantly lower [coefficient: -4.033528, 95%CI: (-6.151498, -1.915559),P < 0.01]. A higher rate of esophageal stenosis was observed following ESD [coefficient: 7.322266, 95%CI: (3.810146, 10.83439), P < 0.001]. A significantly greater number of SCC patients were submitted to surgery (log-odds, ADC: -2.1206 ± 0.6249 vs SCC: 4.1356 ± 0.4038, P < 0.05). The odds for re-classification of tumor stage after endoscopic resection were 53% and 39% for ADC and SCC, respectively. Local tumor recurrence was best predicted by grade 3 differentiation and piecemeal resection, metachronous cancer development by the carcinoma in situ component, and lymph node positivity by lymphovascular invasion. With regard to surgically resected patients: Significant differences in patients with positive lymph nodes were observed between ADC and SCC [coefficient: 1.889569, 95%CI: (0.3945146, 3.384624), P<0.01). In contrast, lymphovascular and microvascular invasion and grade 3 patients between histologic types were comparable, the respective rank order of the predictors of lymph node positivity was: Grade 3, lymphovascular invasion (L+), microvascular invasion (V+), submucosal (Sm) 3 invasion, Sm2 invasion and Sm1 invasion. Histologic type (ADC/SCC) was not included in the model. The best predictors for SCC lymph node positivity were Sm3 invasion and (V+). For ADC, the most important predictor was (L+). CONCLUSION: Local tumor recurrence is predicted by grade 3, metachronous cancer by the carcinoma insitu component, and lymph node positivity by L+. T1b cancer should be treated with surgical resection. 展开更多
关键词 SUPERFICIAL ESOPHAGEAL cancer ENDOSCOPIC resection Mucosal infiltration SUBMUCOSAL involvement Recurrent tumor Controversies in treatment squamous cell carcinoma Adenocarcinoma Lymphatic invasion Vascular invasion SUBMUCOSAL LAYER SUPERFICIAL SUBMUCOSAL LAYER middle third SUBMUCOSAL LAYER Deep third SUBMUCOSAL LAYER ESOPHAGEAL cancer ENDOSCOPIC GASTROinTESTinAL surgical procedures ENDOSCOPIC GASTROinTESTinAL surgery Lymph node dissection Dysplasia
下载PDF
Effect of FGF-BP on angiogenesis in squamous cell carcinoma
8
作者 李为民 陈文彬 《Chinese Medical Journal》 SCIE CAS CSCD 2004年第4期621-623,共3页
关键词 ADULT Aged Aged 80 and over carcinoma squamous cell Carrier Proteins FEMALE Humans MALE middle Aged Neovascularization Pathologic von Willebrand Factor
原文传递
Lower lip recurrent keratoacanthoma:A case report
9
作者 Xian-Guang Liu Xing-Guang Liu +2 位作者 Cai-Jiao Wang Han-Xi Wang Xu-Xia Wang 《World Journal of Clinical Cases》 SCIE 2022年第20期6960-6965,共6页
BACKGROUND This paper introduces a case of recurrent keratoacanthoma(KA).KA is a selfhealing disease.Recurrence after surgical resection is rare.In this case,the local application of retinoic acid ointment after the s... BACKGROUND This paper introduces a case of recurrent keratoacanthoma(KA).KA is a selfhealing disease.Recurrence after surgical resection is rare.In this case,the local application of retinoic acid ointment after the second operation achieved a good prognosis after 2 years of follow-up.CASE SUMMARY A 76-year-old male patient was admitted to the hospital for"lower lip rupture and scab for 3 mo".Treatment:A rectangular incision was made in the healthy tissue about 3 mm outside the periphery of the lower lip mass,and a modified Bernard sliding flap was designed to completely remove the mass.Pathology showed(lower lip)KA.When the patient returned 6 mo after surgery,the middle mucosa of the lower lip had a bulge with a diameter of about 0.5 cm.The boundary was still clear,the surface was ulcerated.A recurrence of lower lip KA was suspected and a fan-shaped incision was performed in the healthy tissue about 5 mm outside the lesion to completely resect.Pathological showed lower lip KA had recurred.Topical application of tretinoin cream was applied once a day for 3 mo.The lower lip wounds were clean at the 2-year postoperative follow-up and the mucosa was normal.CONCLUSION Adjuvant retinoic acid treatment after KA surgical resection can achieve good results. 展开更多
关键词 KERATOACANTHOMA lower lip squamous cell carcinoma Clinical features RECURRENCE Case report
下载PDF
186例Kindler综合征临床和基因突变分析
10
作者 闪莹 左亚刚 《中国医学科学院学报》 CAS CSCD 北大核心 2022年第2期227-235,共9页
目的总结Kindler综合征(KS)的临床表现及基因突变特点,为该类疾病的诊疗提供理论依据。方法汇总分析北京协和医院收治的1例FERMT1基因新突变导致的KS病例和国内外报道的185例患者的临床资料,包括基因类型、临床特点及其并发肿瘤发生的... 目的总结Kindler综合征(KS)的临床表现及基因突变特点,为该类疾病的诊疗提供理论依据。方法汇总分析北京协和医院收治的1例FERMT1基因新突变导致的KS病例和国内外报道的185例患者的临床资料,包括基因类型、临床特点及其并发肿瘤发生的年龄、部位和类型等。结果共收集186例KS患者,男110例、女76例,平均年龄(28±16)岁,其中151例报道了基因突变位点,94例报道了详细的临床表现。KS的主要临床表现有皮肤异色症、童年水疱史、光敏感,次要临床表现有口腔内炎症、掌跖角化、假性并指、吞咽困难、尿道狭窄等。其中口腔内炎症(r=0.234,P=0.023)、掌跖角化(r=0.325,P=0.001)、假性并指(r=0.247,P=0.016)、吞咽困难(r=0.333,P=0.001)、尿道狭窄(r=0.280,P=0.006)与年龄具有显著相关性,32岁以上患者发生概率明显增高。尿道狭窄(χ^(2)=11.292,P=0.001)、肛门狭窄(χ^(2)=4.014,P=0.045)与性别具有显著相关性,男性多于女性。151例患者中发现80种不同的基因突变位点,其中最常见的基因突变位点为c.676C>T。27例KS患者发生41例次肿瘤,鳞状细胞癌占92.7%。鳞状细胞癌发病率与患者所处国别与基因突变位点之间无相关性。结论KS是罕见的先天性大疱性表皮松解症,以FERMT1基因c.676C>T突变最常见,易发生鳞状细胞癌,曝光部位(手、口唇)为主要的发病部位。 展开更多
关键词 Kindler综合征 下唇肿物 鳞状细胞癌 隐性遗传性疾病 伴大疱的先天性皮肤异色症
下载PDF
不同颈部处理方式对全麻下早中期舌鳞状细胞癌淋巴清除及术后复发率的影响
11
作者 何海蕾 胡海东 严晓东 《中国医学创新》 CAS 2023年第29期69-73,共5页
目的:探讨肩胛舌骨上颈淋巴清扫术与舌骨上颈淋巴清扫术在全麻下对早中期舌鳞状细胞癌患者的临床疗效。方法:选取2020年10月—2021年12月赣州市人民医院收治的156例早中期舌鳞状细胞癌患者,随机将其分为对照组与研究组,各78例。对照组... 目的:探讨肩胛舌骨上颈淋巴清扫术与舌骨上颈淋巴清扫术在全麻下对早中期舌鳞状细胞癌患者的临床疗效。方法:选取2020年10月—2021年12月赣州市人民医院收治的156例早中期舌鳞状细胞癌患者,随机将其分为对照组与研究组,各78例。对照组采取舌骨上颈淋巴清扫术治疗,研究组采取肩胛舌骨上颈淋巴清扫术治疗。比较两组淋巴清扫效果、生存质量、转阴率、转阴者复发率及治疗满意度。结果:研究组淋巴清扫总有效率显著高于对照组(P<0.05)。研究组转阴率显著高于对照组(P<0.05);研究组转阴者复发率低于对照组,差异有统计学意义(P<0.05)。治疗后6个月,两组华盛顿医科大学生存质量量表(UW-QOL)评分均较治疗前明显升高,且研究组UW-QOL评分较对照组显著高(P<0.05)。研究组治疗满意度显著高于对照组(P<0.05)。结论:与舌骨上颈淋巴清扫术相比,肩胛舌骨上颈淋巴清扫术疗效更好,且更有助于减少舌鳞状细胞癌复发率、改善生存质量及提升治疗满意度。 展开更多
关键词 早中期舌鳞状细胞癌 舌骨上颈清扫术 肩胛舌骨上颈淋巴清扫术 复发 生存质量
下载PDF
重组人血管内皮抑制素注射液持续静脉泵注联合同步放化疗治疗中晚期肺鳞癌的疗效 被引量:1
12
作者 王锡林 姜妍 曲震 《临床合理用药杂志》 2023年第28期9-12,共4页
目的观察重组人血管内皮抑制素注射液持续静脉泵注联合同步放化疗治疗中晚期肺鳞癌的临床疗效。方法选取2015年1月—2020年12月中国人民解放军第970医院收治住院的中晚期肺鳞癌患者50例,按照随机数字表法分为联合组和对照组,每组25例。... 目的观察重组人血管内皮抑制素注射液持续静脉泵注联合同步放化疗治疗中晚期肺鳞癌的临床疗效。方法选取2015年1月—2020年12月中国人民解放军第970医院收治住院的中晚期肺鳞癌患者50例,按照随机数字表法分为联合组和对照组,每组25例。对照组给予肺癌及纵隔转移淋巴结局部放疗,每周5次,同时给予长春瑞滨+顺铂全身化疗2个周期,放疗结束3周后再给予4个周期全身化疗。联合组在对照组治疗的基础上于每次化疗前4 d给予重组人血管内皮抑制素注射液持续静脉泵注。比较2组患者近期疗效、生存质量改善率和不良反应。结果联合组患者客观缓解率为60.00%,高于对照组的32.00%(χ^(2)=3.945,P=0.047);联合组与对照组患者疾病控制率比较差异无统计学意义(80.00%vs.64.00%,χ^(2)=1.587,P=0.208);联合组患者生存质量改善率为76.00%,高于对照组的48.00%(χ^(2)=4.160,P=0.041);2组患者各项不良反应发生率比较差异无统计学意义(P>0.05)。结论重组人血管内皮抑制素注射液持续静脉泵注联合同步放化疗治疗中晚期肺鳞癌近期临床疗效显著,可提高客观有效率,改善生存质量,且未明显增加不良反应。 展开更多
关键词 肺鳞癌 中晚期 重组人血管内皮抑制素注射液 影像引导放射治疗 化疗 疗效
下载PDF
基于SEER数据库的中耳鳞癌患者的生存分析
13
作者 邹哲飞 顾翔 郭蓓 《中华耳科学杂志》 CSCD 北大核心 2023年第4期498-502,共5页
目的利用监测、流行病学和最终结果(SEER)数据库,研究中耳鳞癌患者的生存结局特征及分析其预后影响因素。方法回顾性分析1975年至2017年SEER数据中被诊断为中耳鳞状细胞癌患者的记录,统计分析患者的生存率以及预后影响因素分析。结果分... 目的利用监测、流行病学和最终结果(SEER)数据库,研究中耳鳞癌患者的生存结局特征及分析其预后影响因素。方法回顾性分析1975年至2017年SEER数据中被诊断为中耳鳞状细胞癌患者的记录,统计分析患者的生存率以及预后影响因素分析。结果分析了97例中耳鳞状细胞癌患者,其疾病特异性生存率(disease-specific survival,DSS)1年生存率、3年生存率及5年生存率分别为58.8%、29.9%和20.6%。筛选出59例符合研究条件的患者行生存分析,单因素COX回归分析显示肿瘤分期与是否行放疗为其预后影响因素(P值分别为0.034和0.010),多因素COX回归分析示:肿瘤分期与是否行放疗为影响预后患者的独立危险因素(P值分别为0.044和0.008)。结论中耳鳞状细胞癌患者的生存预后取决于肿瘤的分期及是否行放疗;远处转移及未行放疗的患者生存率明显降低。 展开更多
关键词 中耳鳞状细胞癌 生存 SEER数据库
下载PDF
不同手术方式对胸中段食管癌的近期和远期疗效评估 被引量:10
14
作者 李杰 田锋 +3 位作者 林长锦 胡健 崔永 高志 《实用临床医药杂志》 CAS 2013年第21期50-52,共3页
目的探讨不同手术方式对胸中段食管癌的近期和远期疗效。方法回顾性分析本院收治的182例食管癌手术患者的临床资料,其中行Ivor-Lewis术(A术)患者131例,行经左胸食管大部切除、主动脉弓上食管胃吻合术(B术,弓上食管胃吻合术)患者51例。对... 目的探讨不同手术方式对胸中段食管癌的近期和远期疗效。方法回顾性分析本院收治的182例食管癌手术患者的临床资料,其中行Ivor-Lewis术(A术)患者131例,行经左胸食管大部切除、主动脉弓上食管胃吻合术(B术,弓上食管胃吻合术)患者51例。对2组患者吻合口瘘、肺部感染等手术并发症进行统计,观察2组患者5年生存率、5年肿瘤复发率,分析患者年龄、性别、手术方法、术后并发症、肿瘤分期和淋巴结转移与食管癌患者的预后关系。结果 A术发生吻合口或胃瘘、吻合口狭窄、喉返神经损伤、乳糜胸、肺部感染、胃扩张、幽门或胃梗阻的概率与B术相比无显著差异(P>0.05);两种手术方式总的并发症发生率比较也无显著差异(χ2=1.927,P=0.165);A术术后5年的生存率为36.64%,而B术术后5年生存率为35.29%,两种术式比较差异无统计学意义(χ2=0.082,P=0.77);A术术后5年肿瘤复发率为71%,而B术术后5年肿瘤复发率为76.47%,差异无统计学意义(χ2=0.41,P=0.52);Cox回归分析结果发现,肿瘤的分期及淋巴结转移与患者的预后密切相关(P=0.005和P=0.027),而与年龄、性别、病变长度、手术方法和术后并发症无显著相关性(P>0.05)。结论 IvorLewis术与经左胸食管大部切除、主动脉弓上食管胃吻合术两种手术方式并不是中段食管癌的预后危险因素,应根据患者的具体情况选择手术方式。 展开更多
关键词 胸中段食管癌 手术方式 Ivor—Lewis术 左胸食管大部切除 主动脉弓上食管胃吻合术
下载PDF
中晚期口腔鳞状细胞癌术前多西他赛联合顺铂及5-氟尿嘧啶诱导化疗的安全性研究 被引量:5
15
作者 杨媛媛 周诺 +3 位作者 蒙宁 黄旋平 黄素华 唐弈遥 《广西医学》 CAS 2015年第11期1550-1552,共3页
目的观察多西他赛联合顺铂及5-氟尿嘧啶(TPF)术前诱导化疗治疗中晚期口腔鳞状细胞癌的安全性。方法46例中晚期口腔鳞状细胞癌患者,其中观察组23例术前给予TPF方案诱导化疗,7~10 d后手术治疗;对照组23例单纯给予手术治疗。观察诱导化... 目的观察多西他赛联合顺铂及5-氟尿嘧啶(TPF)术前诱导化疗治疗中晚期口腔鳞状细胞癌的安全性。方法46例中晚期口腔鳞状细胞癌患者,其中观察组23例术前给予TPF方案诱导化疗,7~10 d后手术治疗;对照组23例单纯给予手术治疗。观察诱导化疗的不良反应及两组术后并发症发生率。结果 TPF诱导化疗的不良反应主要为骨髓抑制、胃肠道反应,患者可耐受。两组术后均并发切口感染、出血、乳糜瘘等,观察组术后并发症发生率为13.0%(3/23),对照组为17.39%(4/23),两组比较差异无统计学意义(P〉0.05)。结论中晚期口腔鳞状细胞癌患者术前TPF诱导化疗,不良反应较轻,对术后并发症无明显影响。 展开更多
关键词 口腔鳞状细胞癌 中晚期 诱导化疗 术前 多西他赛 顺铂 5-氟尿嘧啶 不良反应 并发症
下载PDF
辅助化疗对胸下段食管鳞癌根治术患者预后的影响 被引量:1
16
作者 郭娜 孙云朝 +2 位作者 李德辉 范焕芳 孙春霞 《临床肿瘤学杂志》 CAS 2021年第2期152-158,共7页
目的探讨术后辅助性化疗(POCT)对胸下段食管鳞癌(ESCC)术后患者预后的影响,并探讨其失败模式。方法对符合入组条件的277例胸下段ESCC术后患者进行回顾性分析,Kaplan Meier法绘制OS和DFS曲线,Cox风险比例回归模型分析预后的影响因素,探... 目的探讨术后辅助性化疗(POCT)对胸下段食管鳞癌(ESCC)术后患者预后的影响,并探讨其失败模式。方法对符合入组条件的277例胸下段ESCC术后患者进行回顾性分析,Kaplan Meier法绘制OS和DFS曲线,Cox风险比例回归模型分析预后的影响因素,探讨患者失败模式和死亡原因。结果全组患者中位OS和DFS分别为65个月(95%CI:49.351~80.649)和55个月(95%CI:41.264~68.736)。单因素分析结果显示性别、食管病变造影长度、分化程度、pT分期、pN分期、pTNM分期和化疗周期数分组3均为OS和DFS的影响因素(P<0.05),其中年龄为OS的影响因素(P<0.05)。多因素分析结果显示性别、pTNM分期和化疗周期数分组3均为影响患者OS和DFS的独立预后因素(P<0.05)。亚组分析结果显示POCT可显著性增加T_(3)/T_(4)期和淋巴结转移阳性患者的OS和DFS(P<0.05)。全组共有85例(30.7%)患者出现局部区域失败,47例(17.0%)患者出现远处脏器转移。95例(63.3%)患者死因与肿瘤密切相关。结论POCT可以提高胸下段ESCC术后患者的长期生存,尤其可以改善术后淋巴结病理阳性和分期较晚患者的预后,建议患者周期数为2~3周期。 展开更多
关键词 食管鳞癌 胸下段 根治性手术 术后化疗 预后 失败模式
下载PDF
复方斑蝥胶囊联合GP方案治疗中晚期肺鳞癌的临床效果 被引量:11
17
作者 黄建清 何爱国 +4 位作者 李亮 蓝轶 罗飞燕 吴冬 吴邦强 《实用癌症杂志》 2019年第6期968-970,共3页
目的 观察复方斑蝥胶囊联合吉西他滨+顺铂(GP方案)治疗中晚期肺鳞癌的临床疗效。方法 选取62例中晚期肺鳞癌患者作为研究对象,采用随机数字表法将其分为观察组与对照组,每组31例。对照组给予GP方案进行治疗,观察组在对照组基础上同时给... 目的 观察复方斑蝥胶囊联合吉西他滨+顺铂(GP方案)治疗中晚期肺鳞癌的临床疗效。方法 选取62例中晚期肺鳞癌患者作为研究对象,采用随机数字表法将其分为观察组与对照组,每组31例。对照组给予GP方案进行治疗,观察组在对照组基础上同时给予复方斑蝥胶囊进行治疗。治疗后,评价2组的近期疗效。治疗前后,分别检测2组患者免疫功能指标含量,主要包括IgM、IgG、IgA、CD4+及CD8+。治疗期间,密切观察2组患者的毒副作用发生情况,主要观察指标包括恶心呕吐、腹痛腹泻、骨髓抑制、皮疹、发热及神经毒性等。结果 治疗后,观察组疾病控制率明显高于对照组(P<0.05)。治疗期间,观察组的恶心呕吐、腹痛腹泻、骨髓抑制、皮疹、发热及神经毒性的发生率均明显低于对照组(P<0.05)。治疗后,观察组IgM、IgG、IgA、CD4+及CD8+均明显高于对照组(P<0.05)。结论 复方斑蝥胶囊联合GP方案治疗中晚期肺鳞癌疗效较好,可有效改善患者免疫功能,降低化疗毒副作用。 展开更多
关键词 复方斑蝥胶囊 GP方案 中晚期肺鳞癌
下载PDF
中下段食管鳞状细胞癌Sweet术后颈部食管胃吻合口瘘的高危因素分析 被引量:8
18
作者 严英光 《河北医药》 CAS 2018年第19期2961-2963,2967,共4页
目的探讨中下段食管鳞状细胞癌Sweet术后颈部食管胃吻合口瘘的高危因素分析。方法通过对2015年2月至2017年3月就诊收治的280例择期行Sweet术治疗的食管胸中下段鳞癌患者临床资料做回顾性分析,记录所有患者年龄、性别、合并基础病情况、... 目的探讨中下段食管鳞状细胞癌Sweet术后颈部食管胃吻合口瘘的高危因素分析。方法通过对2015年2月至2017年3月就诊收治的280例择期行Sweet术治疗的食管胸中下段鳞癌患者临床资料做回顾性分析,记录所有患者年龄、性别、合并基础病情况、肿瘤部位、TNM分期、制作管状胃、吻合方式、吻合口包埋、术后肺部感染、术后纤维支气管镜吸痰等。采用logistic回归分析颈部食管胃吻合口瘘发生的影响因素。结果本组280例患者均成功行Sweet手术,共有50例(17.86%)患者出现颈部食管胃吻合口瘘。年龄≥60岁、性别、合并糖尿病、制作管状胃、术后肺部感染、术后应用纤维支气管镜吸痰是中下段食管鳞状细胞癌Sweet术后颈部食管胃吻合口瘘发生的影响因素(P<0.05)。制作管状胃(OR=1.921,95%CI:1.065~3.466)、术后肺部感染(OR=1.881,95%CI:1.047~3.380)、术后纤维支气管镜吸痰(OR=1.898,95%CI:1.151~3.130)是食管癌Sweet术后颈部食管胃吻合口瘘发生的独立危险因素(P<0.05)。结论制作管状胃、术后肺部感染、术后纤维支气管镜吸痰是中下段食管鳞状细胞癌Sweet术后颈部食管胃吻合口瘘发生的独立危险因素,应当注重并提前干预,可减少颈部食管胃吻合口瘘的发生。 展开更多
关键词 中下段食管鳞状细胞癌 Sweet术后 食管胃吻合口瘘 高危因素
下载PDF
淋巴结清扫总数对胸段食管鳞状细胞癌患者预后的影响 被引量:2
19
作者 李畅波 莫俊贤 《广西医学》 CAS 2021年第7期819-823,828,共6页
目的探讨淋巴结清扫总数对胸段食管鳞状细胞癌患者预后的影响。方法回顾性分析行食管癌根治术治疗的121例胸段食管鳞癌患者的临床资料。采用受试者工作特征(ROC)曲线及约登指数最大法确定淋巴结清扫总数的最佳截断点,采用Kaplan-Meier... 目的探讨淋巴结清扫总数对胸段食管鳞状细胞癌患者预后的影响。方法回顾性分析行食管癌根治术治疗的121例胸段食管鳞癌患者的临床资料。采用受试者工作特征(ROC)曲线及约登指数最大法确定淋巴结清扫总数的最佳截断点,采用Kaplan-Meier法绘制生存曲线,采用Cox回归模型分析相关临床病理因素与患者预后的关系。结果ROC曲线法及约登指数最大法确定淋巴结清扫总数最佳截断点为15枚(曲线下面积为0.667,P<0.001)。相对于淋巴结清扫总数<15枚的患者,淋巴结清扫总数≥15枚的胸段食管鳞癌患者的预后更好(P<0.05)。多因素Cox回归分析结果显示,淋巴结清扫总数≥15枚和术后辅助治疗是影响患者预后的保护因素,而淋巴结高分期及术后复发和转移是影响患者预后的危险因素(均P<0.05)。结论淋巴结清扫总数、术后辅助治疗、淋巴结分期、术后复发或转移均为影响胸段食管鳞癌患者预后的独立因素,其中淋巴结清扫总数≥15枚为胸段食管鳞癌患者预后的保护因素。 展开更多
关键词 食管鳞状细胞癌 胸段 淋巴结清扫总数 预后 临床病理特征 影响因素
下载PDF
下颌骨边缘性切除术对涉及下颌骨的口腔鳞癌患者的临床疗效研究 被引量:3
20
作者 李海朋 《实用癌症杂志》 2022年第1期133-135,共3页
目的探讨下颌骨边缘性切除术治疗涉及下颌骨的口腔鳞癌患者的临床疗效研究。方法选取涉及下颌骨的口腔鳞癌患者64例,按手术方案不同分为观察组(n=32)和对照组(n=32),对照组予以下颌骨节段切除术,观察组予以下颌骨边缘性切除术。对比两... 目的探讨下颌骨边缘性切除术治疗涉及下颌骨的口腔鳞癌患者的临床疗效研究。方法选取涉及下颌骨的口腔鳞癌患者64例,按手术方案不同分为观察组(n=32)和对照组(n=32),对照组予以下颌骨节段切除术,观察组予以下颌骨边缘性切除术。对比两组围术期情况、预后情况、术前、术后1个月Friction颞下颌关节功能紊乱指数(Friction指数)[肌肉压痛指数(PI)、颞下颌关节功能障碍指数(DI)]。结果观察组术中出血量少于对照组,手术时间、住院时间短于对照组(P<0.05);术后1个月,观察组PI、DI评分较对照组低(P<0.05);观察组1年生存率83.33%(25/30)、3年生存率66.67%(20/30)、1年复发率10.00%(3/30)、3年复发率26.67%(8/30)与对照组[80.65%(25/31)、61.29%(19/31)、12.90%(4/31)、29.03%(9/31)]相比无显著差异(P>0.05)。结论采用下颌骨边缘性切除术治疗涉及下颌骨的口腔鳞癌患者,可缩短手术时间,减少出血量,加快患者恢复进程,改善Friction指数,且生存率高,复发率低,可改善预后。 展开更多
关键词 口腔鳞癌 下颌骨边缘性切除术 下颌骨节段切除术 围术期情况 Friction指数
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部